Clinical Trial Update: An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD) [Phase 3]

View source ↗

Summary

Phase 3 international trial evaluating diagnostic efficacy of Flurpiridaz (18F) injection PET MPI for detecting Coronary Artery Disease has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Flurpiridaz (18F) Injection (Flurpiridaz (18F))

Snippet

Sponsor: GE Healthcare | Conditions: Coronary Artery Disease (CAD) | Phase 3 | Status: COMPLETED | Results posted: 2023-07-12